Core B: Gene Modulation with RNAi and CRISPER
Core B: Gene Modulation with RNAi and CRISPER
批准号:
10330429
负责人:
CHRISTOPHER VAKOC
金额:
$41.82万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-02-10 至 2023-01-31
关键词:
Algorithm DesignAnimalsAntineoplastic AgentsAreaBiologicalBiological AssayBloodBreastCRISPR libraryCRISPR screenCRISPR/Cas technologyCell LineCellsCloningClustered Regularly Interspaced Short Palindromic RepeatsCodeCollaborationsCommunitiesComputational algorithmCultured CellsCustomDependenceDevelopmentDrug TargetingEnsureExposure toExpression LibraryFamilyFundingGene SilencingGenerationsGenesGeneticGuide RNAHumanLaboratoriesLibrariesLightLiverMalignant NeoplasmsMammalian CellMediatingMethodologyMethodsMolecularMusMutagenesisMutationNCI Center for Cancer ResearchPerformancePhosphotransferasesProceduresProteinsRNA InterferenceRNA libraryRNAi vectorResearch PersonnelScanningServicesStructureSystemTechniquesTechnologyTertiary Protein StructureTherapeuticTumor Suppressor GenesUntranslated RNAValidationWorkbasecancer celldesignexperimental studyexpression vectorfunctional genomicsgene functiongenetic analysisgenome editinggenome-wideimprovedin vivoinnovationinsertion/deletion mutationinterestknock-downmeetingsmembernovelprediction algorithmprogramsresponsescaffoldscreeningsensorsmall hairpin RNAtechnology developmenttherapeutic targettooltumortumor initiationvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY-CORE B
Core B supports every project within the Program by providing access to state-of-the-art CRISPR-Cas9 and
RNAi tools. Short hairpin RNAs (shRNAs) were developed with the support of this program, and ongoing
innovations by Core B and Program investigators have helped to make these extremely powerful biological
tools. During the past funding period, the Core devised a novel algorithm for predicting shRNA potency, which
led to the generation of a 5th version of RNAi libraries corresponding to annotated protein coding genes in
humans and mice. Technology has also been developed for using CRISPR-Cas9 screening to expose
functionally important protein domains. During the upcoming period of requested support, the Core proposes to
aid Program investigators through five general aims. First, the program will continue providing access to state-
of-the-art RNAi vectors and CRISPR-Cas9 vectors and procedures for analyzing either single gene
knockdowns or for performing pooled RNAi/CRISPR screens. Second, the Core will provide Program
investigators with access to the mouse and human version 5 shRNA library and will compile sub-libraries upon
request. Third, the Core will construct custom CRISPR-scanning libraries for performing structure-function
analysis on genes of interest within each Program. Fourth, the Core will produce custom domain-focused
CRISPR libraries to allow for interrogation and discovery cancer drug targets in various contexts. Fifth, the
Core will carry on its efforts to improve CRISPR-Cas9 technologies, and make those innovations available to
the Program and to the scientific community at large.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the SCP4 pathway as a multi-catalytic signaling dependency in acute myeloid leukemia
-
批准号:10753227
-
项目类别:
-
资助金额:$74.25万
-
财政年份:2023
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer
-
批准号:10221648
-
项目类别:
-
资助金额:$43.92万
-
财政年份:2019
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer
-
批准号:9980811
-
项目类别:
-
资助金额:$43.92万
-
财政年份:2019
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
Targeting aberrant enhancer landscapes in pancreatic cancer
-
批准号:10199961
-
项目类别:
-
资助金额:$41.31万
-
财政年份:2019
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer
-
批准号:10693821
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2019
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
Targeting aberrant enhancer landscapes in pancreatic cancer
-
批准号:9816984
-
项目类别:
-
资助金额:$41.31万
-
财政年份:2019
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
Elucidating the function of PAX3-FOXO1 in rhabdomyosarcoma with molecular reporters and next-generation genome editing
-
批准号:10064134
-
项目类别:
-
资助金额:$22.44万
-
财政年份:2019
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer
-
批准号:10450100
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2019
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
Targeting aberrant enhancer landscapes in pancreatic cancer
-
批准号:10436243
-
项目类别:
-
资助金额:$40.48万
-
财政年份:2019
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
Targeting aberrant enhancer landscapes in pancreatic cancer
-
批准号:10661753
-
项目类别:
-
资助金额:$40.48万
-
财政年份:2019
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
-
批准号:10306382
-
项目类别:
-
资助金额:$54.11万
-
财政年份:2013
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
-
批准号:8478858
-
项目类别:
-
资助金额:$54.9万
-
财政年份:2013
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
-
批准号:8828135
-
项目类别:
-
资助金额:$55.78万
-
财政年份:2013
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
-
批准号:9237236
-
项目类别:
-
资助金额:$55.78万
-
财政年份:2013
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
-
批准号:10532683
-
项目类别:
-
资助金额:$54.11万
-
财政年份:2013
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
-
批准号:10078598
-
项目类别:
-
资助金额:$55.22万
-
财政年份:2013
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
-
批准号:8635318
-
项目类别:
-
资助金额:$53.26万
-
财政年份:2013
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
Project 4: Transcriptional Coactivators and Enhancers in Human Cancer
-
批准号:10330426
-
项目类别:
-
资助金额:$54.03万
-
财政年份:1997
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
Targeting Transcription and Splicing in Cancer
-
批准号:10555931
-
项目类别:
-
资助金额:$288.0万
-
财政年份:1997
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
Core A: Administration
-
批准号:10555935
-
项目类别:
-
资助金额:$20.74万
-
财政年份:1997
-
负责人:CHRISTOPHER VAKOC
-
依托单位:
海外基金